Author: Lopez, LeAnn; Sang, Peter C.; Tian, Yun; Sang, Yongming
Title: Dysregulated Interferon Response Underlying Severe COVID-19 Cord-id: 143bbpkp Document date: 2020_12_13
ID: 143bbpkp
Snippet: Innate immune interferons (IFNs), including type I and III IFNs, constitute critical antiviral mechanisms. Recent studies reveal that IFN dysregulation is key to determine COVID-19 pathogenesis. Effective IFN stimulation or prophylactic administration of IFNs at the early stage prior to severe COVID-19 may elicit an autonomous antiviral state, restrict the virus infection, and prevent COVID-19 progression. Inborn genetic flaws and autoreactive antibodies that block IFN response have been signifi
Document: Innate immune interferons (IFNs), including type I and III IFNs, constitute critical antiviral mechanisms. Recent studies reveal that IFN dysregulation is key to determine COVID-19 pathogenesis. Effective IFN stimulation or prophylactic administration of IFNs at the early stage prior to severe COVID-19 may elicit an autonomous antiviral state, restrict the virus infection, and prevent COVID-19 progression. Inborn genetic flaws and autoreactive antibodies that block IFN response have been significantly associated with about 14% of patients with life-threatening COVID-19 pneumonia. In most severe COVID-19 patients without genetic errors in IFN-relevant gene loci, IFN dysregulation is progressively worsened and associated with the situation of pro-inflammation and immunopathy, which is prone to autoimmunity. In addition, the high correlation of severe COVID-19 with seniority, males, and individuals with pre-existing comorbidities will be plausibly explained by the coincidence of IFN aberrance in these situations. Collectively, current studies call for a better understanding of the IFN response regarding the spatiotemporal determination and subtype-specificity against SARS-CoV-2 infections, which are warranted to devise IFN-related prophylactics and therapies.
Search related documents:
Co phrase search for related documents- lung blood and lupus erythematosus: 1
- lung epithelium and macrophage activation: 1, 2
- lung immune cell and macrophage activation: 1, 2
- lung inflammation and lupus erythematosus: 1, 2, 3, 4
- lung inflammation and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- lung inflammation and macrophage activation syndrome: 1, 2
- lupus erythematosus and macrophage activation: 1, 2, 3, 4, 5
- lupus erythematosus and macrophage activation syndrome: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date